Partner
Aaron Gardner helps clients navigate transactions spanning the entire product life cycle and across therapeutic areas and modalities, frequently involving the cutting-edge technologies that rapidly change the face of medicine. Aaron has extensive experience structuring and negotiating high-stakes deals in the pharmaceutical, biotechnology, medical and consumer nutrition sectors, including mergers, acquisitions and divestitures; private equity transactions; and licensing and collaborations.
Before joining Latham, Aaron was a partner at another global law firm. He previously served as senior M&A counsel for a global biopharmaceutical company, which provided him with a real-world understanding of the in-house corporate legal function and substantial experience counseling corporate executives on a wide range of legal and commercial issues.